Jennifer T. Miranda-Balderas
Tlalpan, DIF 14080, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Disrupted Neutrophil and Myeloid Cell Homeostasis and Effector Dysfunction Drive Vasculopathy in Idiopathic Inflammatory Myopathies.
Journal: Cells
Published: March 12, 2026
Integrated metabolomic and cytokine profiling reveals biomarkers across the clinical spectrum of lupus nephritis.
Journal: Frontiers in immunology
Published: January 13, 2026
Clinical, immunological and metabolomic risk factors associated with fibromyalgia in a cohort of patients with idiopathic inflammatory myopathies.
Journal: Frontiers in immunology
Published: January 13, 2026
Role of innate immunity in the development of cancer immunotherapy immune-mediated adverse events.
Journal: Frontiers in immunology
Published: December 24, 2025
The Refractory DermatoMyositis Index (ReDMI): a clinical tool to predict refractory disease in patients with dermatomyositis.
Journal: Clinical and experimental rheumatology
Published: June 18, 2025
Myeloid-derived suppressor cells and monocytes are biomarkers of the clinical phenotype and activity of psoriatic disease.
Journal: Rheumatology (Oxford, England)
Published: May 05, 2025
Characterization of anti-neutrophil extracellular traps (NET) antibodies according to systemic lupus erythematosus clinical phenotypes.
Journal: Immunologic research
Published: November 02, 2024
Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot study.
Journal: Infectious diseases (London, England)
Published: January 13, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026